Cita APA

Rischin, D., Harrington, K. J., Greil, R., Soulières, D., Tahara, M., Castro, G. d., . . . Burtness, B. (2022). Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.

Citación estilo Chicago

Rischin, Danny, et al. Pembrolizumab Alone or With Chemotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Health-related Quality-of-life Results From KEYNOTE-048. 2022.

Cita MLA

Rischin, Danny, et al. Pembrolizumab Alone or With Chemotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Health-related Quality-of-life Results From KEYNOTE-048. 2022.